BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

942 related articles for article (PubMed ID: 32352397)

  • 1. The hemocyte counts as a potential biomarker for predicting disease progression in COVID-19: a retrospective study.
    Zheng Y; Zhang Y; Chi H; Chen S; Peng M; Luo L; Chen L; Li J; Shen B; Wang D
    Clin Chem Lab Med; 2020 Jun; 58(7):1106-1115. PubMed ID: 32352397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of severe illness due to COVID-19 based on an analysis of initial Fibrinogen to Albumin Ratio and Platelet count.
    Bi X; Su Z; Yan H; Du J; Wang J; Chen L; Peng M; Chen S; Shen B; Li J
    Platelets; 2020 Jul; 31(5):674-679. PubMed ID: 32367765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic profile and clinical implications of hematological parameters in hospitalized patients with coronavirus disease 2019.
    Ding X; Yu Y; Lu B; Huo J; Chen M; Kang Y; Lou J; Liu Z
    Clin Chem Lab Med; 2020 Jul; 58(8):1365-1371. PubMed ID: 32441666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China.
    Fu J; Kong J; Wang W; Wu M; Yao L; Wang Z; Jin J; Wu D; Yu X
    Thromb Res; 2020 Aug; 192():3-8. PubMed ID: 32407937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis.
    Henry BM; de Oliveira MHS; Benoit S; Plebani M; Lippi G
    Clin Chem Lab Med; 2020 Jun; 58(7):1021-1028. PubMed ID: 32286245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A nomogram for predicting mortality in patients with COVID-19 and solid tumors: a multicenter retrospective cohort study.
    Liu C; Li L; Song K; Zhan ZY; Yao Y; Gong H; Chen Y; Wang Q; Dong X; Xie Z; Ou CQ; Hu Q; Song Q
    J Immunother Cancer; 2020 Sep; 8(2):. PubMed ID: 32895296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic changes of D-dimer and neutrophil-lymphocyte count ratio as prognostic biomarkers in COVID-19.
    Ye W; Chen G; Li X; Lan X; Ji C; Hou M; Zhang D; Zeng G; Wang Y; Xu C; Lu W; Cui R; Cai Y; Huang H; Yang L
    Respir Res; 2020 Jul; 21(1):169. PubMed ID: 32620118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics and risk factors of patients with severe COVID-19 in Jiangsu province, China: a retrospective multicentre cohort study.
    Liu S; Luo H; Wang Y; Cuevas LE; Wang D; Ju S; Yang Y
    BMC Infect Dis; 2020 Aug; 20(1):584. PubMed ID: 32762665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil to CD4+ lymphocyte ratio as a potential biomarker in predicting virus negative conversion time in COVID-19.
    Wang H; Zhang Y; Mo P; Liu J; Wang H; Wang F; Zhao Q
    Int Immunopharmacol; 2020 Aug; 85():106683. PubMed ID: 32531713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction for Progression Risk in Patients With COVID-19 Pneumonia: The CALL Score.
    Ji D; Zhang D; Xu J; Chen Z; Yang T; Zhao P; Chen G; Cheng G; Wang Y; Bi J; Tan L; Lau G; Qin E
    Clin Infect Dis; 2020 Sep; 71(6):1393-1399. PubMed ID: 32271369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Tool for Early Prediction of Severe Coronavirus Disease 2019 (COVID-19): A Multicenter Study Using the Risk Nomogram in Wuhan and Guangdong, China.
    Gong J; Ou J; Qiu X; Jie Y; Chen Y; Yuan L; Cao J; Tan M; Xu W; Zheng F; Shi Y; Hu B
    Clin Infect Dis; 2020 Jul; 71(15):833-840. PubMed ID: 32296824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormalities of peripheral blood system in patients with COVID-19 in Wenzhou, China.
    Sun S; Cai X; Wang H; He G; Lin Y; Lu B; Chen C; Pan Y; Hu X
    Clin Chim Acta; 2020 Aug; 507():174-180. PubMed ID: 32339487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of progression from moderate to severe coronavirus disease 2019: a retrospective cohort.
    Cheng B; Hu J; Zuo X; Chen J; Li X; Chen Y; Yang G; Shi X; Deng A
    Clin Microbiol Infect; 2020 Oct; 26(10):1400-1405. PubMed ID: 32622952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage.
    Liu J; Liu Y; Xiang P; Pu L; Xiong H; Li C; Zhang M; Tan J; Xu Y; Song R; Song M; Wang L; Zhang W; Han B; Yang L; Wang X; Zhou G; Zhang T; Li B; Wang Y; Chen Z; Wang X
    J Transl Med; 2020 May; 18(1):206. PubMed ID: 32434518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The underlying changes and predicting role of peripheral blood inflammatory cells in severe COVID-19 patients: A sentinel?
    Sun DW; Zhang D; Tian RH; Li Y; Wang YS; Cao J; Tang Y; Zhang N; Zan T; Gao L; Huang YZ; Cui CL; Wang DX; Zheng Y; Lv GY
    Clin Chim Acta; 2020 Sep; 508():122-129. PubMed ID: 32417210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of neutrophil-lymphocyte ratio and lymphocyte-monocyte ratio in the prognosis of type 2 diabetics with COVID-19.
    Liu G; Zhang S; Hu H; Liu T; Huang J
    Scott Med J; 2020 Nov; 65(4):154-160. PubMed ID: 32865157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Retrospective Study of the C-Reactive Protein to Lymphocyte Ratio and Disease Severity in 108 Patients with Early COVID-19 Pneumonia from January to March 2020 in Wuhan, China.
    Yang M; Chen X; Xu Y
    Med Sci Monit; 2020 Sep; 26():e926393. PubMed ID: 32914767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using IL-2R/lymphocytes for predicting the clinical progression of patients with COVID-19.
    Hou H; Zhang B; Huang H; Luo Y; Wu S; Tang G; Liu W; Mao L; Mao L; Wang F; Sun Z
    Clin Exp Immunol; 2020 Jul; 201(1):76-84. PubMed ID: 32365221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-6-based mortality risk model for hospitalized patients with COVID-19.
    Laguna-Goya R; Utrero-Rico A; Talayero P; Lasa-Lazaro M; Ramirez-Fernandez A; Naranjo L; Segura-Tudela A; Cabrera-Marante O; Rodriguez de Frias E; Garcia-Garcia R; Fernández-Ruiz M; Aguado JM; Martinez-Lopez J; Lopez EA; Catalan M; Serrano A; Paz-Artal E
    J Allergy Clin Immunol; 2020 Oct; 146(4):799-807.e9. PubMed ID: 32710975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CURB-65 may serve as a useful prognostic marker in COVID-19 patients within Wuhan, China: a retrospective cohort study.
    Guo J; Zhou B; Zhu M; Yuan Y; Wang Q; Zhou H; Wang X; Lv T; Li S; Liu P; Yang Y; He P; Zhang P
    Epidemiol Infect; 2020 Oct; 148():e241. PubMed ID: 32998791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.